MedPath

Buphenyl Therapy for Byler's Disease

Conditions
Byler Disease
Registration Number
NCT01784718
Lead Sponsor
University of Pittsburgh
Brief Summary

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
NO_LONGER_AVAILABLE
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Byler Disease
  • Cholestasis unresponsive to pharmacologic therapy
Exclusion Criteria
  • Allergy/Hypersensitivity to Buphenyl

Study & Design

Study Type
EXPANDED_ACCESS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath